Advisory Board October 21, 2024

Recently, retail pharmacies like CVS and Walgreens have faced significant financial difficulties, leading them to lay off workers, reduce services, and halt previously announced expansion plans.

5 PBM strategies to watch

CVS discontinues infusion services as part of cost-cutting measures

Over the last few years, CVS has struggled with declining profit margins at its retail pharmacies, as well as rising costs of patient care through its insurance unit Aetna, which generates around a third of the company’s revenue. So far, CVS has cut its 2024 earnings forecast for three straight quarters.

Currently, the company is conducting a strategic review of options, including a potential breakup of its businesses, people familiar with the matter said. CVS has also met with...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
Survey Suggests Pharma Industry Still Struggling with Digital Transformation
Will Walgreens’ store closures disrupt its clinical trial aims?
340B Legal Challenges Highlight The Appetite For Innovation That Supports The Program’s Goals
How Agencies Should Decide Which Costly Drugs To Target With Government March-In Rights

Share This Article